Sepsis, Septic Shock

3

Review clinical trials related to Sepsis, Septic Shock. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Multicenter Symphony™ IL-6 Monitoring Sepsis ED Pilot Study

The primary objective of this study is to establish an IL-6 concentration cutoff that predicts sepsis or septic shock (according to the Third International Consensus Definitions (Sepsis-3 criteria)) in patients who are admitted or are intended to be admitted to the hospital from the emergency department with suspected infection.

Participants needed: 450
Trial details
Age: 22+Biological sex: AllType: ObservationalSponsor: Bluejay Diagnostics, Inc.Updated: Jul 2, 2026Locations: 5
Eligibility criteria

Adult patients (≥22 years of age) [+16]

Prisoners or imprisonment at time of enrollment [+4]

Status: Recruiting

Multicenter Symphony IL-6 Monitoring Sepsis ICU Validation Study

The primary objective of this study is to validate a pre-defined IL-6 concentration cutoff that predicts 28-day mortality in patients who are admitted or are intended to be admitted to the ICU diagnosed with sepsis or septic shock.

Participants needed: 700
Trial details
Age: 22+Biological sex: AllType: ObservationalSponsor: Bluejay Diagnostics, Inc.Updated: Feb 3, 2026Locations: 5
Eligibility criteria

Adult patients (≥22 years of age) [+5]

Prisoners or imprisonment at time of enrollment [+2]

Status: Recruiting

Role of Transposable Elements in Septic Immune Aging

The goal of this observational study is to learn about how transposable element levels affect the patient outcomes in sepsis. The main questions it aims to answer is: 1. Do transposable elements prematurely age the immune systems of patients with sepsis? 2. Do transposable elements correlate with increased mortality in patients with sepsis in the ICU? 3. Do transposable elements correlate with increased amount of secondary infections in patients with sepsis in the ICU? Participants will have blood drawn from them but will not be subjected to additional interventions.

Participants needed: 116
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: University of California, San FranciscoUpdated: Jan 30, 2026Locations: 1Duration: 6 Weeks
Eligibility criteria

Age 18 or older [+2]

Patients on organ transplantation immunosuppression [+6]